Count Me In: Partnering with Patients to Define the Landscape of Rare, Aggressive Sarcomas
Attend this seminar to discover how the nonprofit research initiative “Count Me In” is partnering researchers with patients to understand rare, aggressive cancers. Harvard Medical School’s Dr. Katherine Janeway will elaborate on the initiative’s particular work with osteosarcoma and leiomyosarcoma.
The Cancer MoonshotSM Seminar Series showcases the research progress of different Cancer Moonshot initiatives.
The Cancer Moonshot Blue Ribbon Panel of scientific experts created a report outlining 10 recommendations. These recommendations are meant to accelerate progress in cancer prevention, diagnosis, and treatment.
Dr. Janeway is an associate professor of pediatrics at Harvard Medical School and a senior physician of pediatric oncology at Dana-Farber Cancer Institute.
Upcoming Events
- Leveraging Optical Imaging and Data Science to Enable Precision Intervention in Brain Tumor SurgeryNovember 26, 2024Evaluating AI Models: Benchmarking and FairnessNovember 26, 20242024 U.S. Southeast Healthcare Innovation SummitDecember 04, 2024Molecular Characterization Initiative (MCI) Update: Pediatric Soft Tissue SarcomasDecember 10, 2024AI-Foundational Models for Cancer Imaging BiomarkersDecember 17, 2024